ebbu
@poweredbyebbu
Creators of the first true cannabis isolate formulations using cannabinoid/terpene ratios, backed by cellular pharmacology research. #patentspending
ID: 3406898290
http://www.ebbu.com 07-08-2015 07:20:10
94 Tweet
199 Takipçi
19 Takip Edilen
ebbu and its team of cannabis scientists have “set out to become the world’s polypharmacological leader by studying the entourage of what’s going on inside of our bodies,” according to TerpsAndTestingMag. Here's why: #entourageeffect bit.ly/2MkAuSt
He never stops: This is our Founder and CEO Jon Cooper speaking to Cannabis & Tech Today and the @CWCBExpo World Congress & Business Exposition in Los Angeles. Cooper also gave a presentation about “#Cannabis Pharmacology and the Entourage Effect” while there. #CWCBExpo
“By rescheduling this FDA-approved #CBD medicine, the DEA is confirming there are legitimate medical properties to this cannabinoid, which is an historic step forward for cannabis and its many components,” Jon Cooper, ebbu’s CEO, tells Proactive USA. proactiveinvestors.com/companies/news…
Next week: ebbu Founder and CEO Jon Cooper will speak about “#Terpenes and the Entourage Effect: More Than The Aroma” and also on the panel “Cannabis, Food, Beverage And Branding: Macro Trends Driving Innovation” at the New West Summit 5 in #Oakland. newwestsummit.com/schedule/
THIS WEEK: Our Founder and CEO Jon Cooper is headed to California for the New West Summit 5 to speak about the future of cannabinoid extraction and cannabis-infused beverages. Get the details on this tech-centric Oakland conference: #NewWestSummit newwestsummit.com